English हिन्दी
Connect with us

Latest world news

Netanyahu’s fait accompli to Trump

Published

on

Netanyahu’s fait accompli to Trump

[vc_row][vc_column][vc_column_text]In a controversial move, the Israeli Knesset goes ahead with legalising 4,000 West Bank settlement homes retroactively

By Sujit Bhar

When hubris piggy-backs a high dose of self-confidence, the yield is an attitude that refuses to see reality as it is, and even refuses to address situations within social and legal parameters of the world. One can be forgiven for thinking the simile is vis-à-vis US President Donald J Trump. You are correct in your assumption, in some ways, and wrong as well.

For, this is about Israeli Prime Minister Benjamin Netanyahu.

It was just the other day that the White House rebuked Israel for its decision to build more settlements in the West Bank. Yet on February 6, Israel’s Knesset passed a law that legalised—and retroactively too—no less than 4,000 settlement homes to be built on land that is privately held by Palestinians.

Which means that Netanyahu has not only thumbed his nose at the White House, but has also agreed to take on massive international outrage and an unending series of lawsuits in his stride.

On February 2, White House spokesman Sean Spicer had said in a statement: “While we don’t believe the existence of settlements is an impediment to peace, the construction of new settlements or the expansion of existing settlements beyond the current borders may not be helpful.”

“The Trump administration has not taken an official position on settlement activity and looks forward to continuing discussions, including with Prime Minister (Benjamin) Netanyahu when he visits with President Trump later this month,” Spicer had added.

While the statement surprised many, considering Trump’s pre-election position vis-a-vis Israel, the latter had made up its mind. Reacting to Spicer, Danny Danon, Israel’s ambassador to the UN, had put out a carefully worded reply. He told Israel Radio: “It’s too early to tell… I would not categorise this as a U-turn by the US administration but the issue is clearly on their agenda… the issue will be discussed when the prime minister (Netanyahu) meets the president in Washington. We will not always agree on everything.”

Back home, Israelis, it seems, refused to wait so long. One believes Netanyahu wants to hand Trump a fait accompli when they meet. That would be difficult for Trump to disengage from, given his original stand.

On February 6, there as a debate in the Knesset, before voting on the Bill took place. In his reply, Israeli cabinet minister Ofir Akunis reportedly said: “We are voting tonight on our right to the land. We are voting tonight on the connection between the Jewish people and its land. This whole land is ours. All of it.”

Total disregard for law

This is clear hubris, a total disregard for international law and even a disregard for the UN Security Council’s December 23 resolution that demanded the stoppage of further settlement activity on occupied Palestinian territory. It was a vote taken in US abstention, but it remains a legal document nevertheless.

This act was, obviously, not worked out through negotiations. When it becomes as law—it is expected to be challenged in the Israeli Supreme Court—it will give the administration legal teeth to confiscate land and hand out whatever compensation the administration deems fit. Such compensation can be money or alternative land, which is surely not there.

The problem in the West Bank is that it is on the border and around disputed land. International laws regarding this have little possibility of being implemented in this area.

The land agreement worked out with international arbitration after Israeli victory in the six-day war of 1967, has neither been fully accepted by Israel nor ratified by the Palestinians. Hence the entire West Bank and even the Gaza Strip remains disputed.

However, with the Palestinian Authority being recognised worldwide today, the “compensation” package is probably just a face-saver. If a Palestinian landowner refuses to part with his land, he will be forced to. That is the ground reality.

The Twist in the Tale

Here lies a twist. The way Netanyahu has been acting it seems as if he has always been against risking the wrath of the world in resuming building on the West Bank. There was, reportedly, huge argument and shouting during the voting process before it was passed 60-52 in the 120-member Knesset.

It has been reported that some spectators in visitors’ seats had shown a black cloth in protest. It is also true that Netanyahu has been concerned about possible international censure and had wanted to wait till his meeting with Trump later this month. This, however, was a ploy to try and sensitize the US regarding the issue and brandishing this support while facing the world. To him, this would have given it a legitimate tinge, however weird that may be.

His dilly-dallying with the law was clear when he had told reporters in London that he was okay with the law going through, but withdrawing into a shell thereafter, probably because of Spicer’s statement.

Also read: Common ground for Trump, Netanyahu, Modi

Hark back to the Security Council decision where ex-president Barack Obama (he was still in office at that time) pushed this resolution through the 15-member council, comprising interesting countries: New Zealand, Malaysia, Venezuela and Senegal. Even Egypt, which had initially been interested, quietly withdrew under pressure from Israel and Trump.

Before that Trump had issued an unofficial call for a veto to the bill. Israel had supported it.

It is also pertinent to recall that Netanyahu was livid, calling the vote “shameful”. He had summoned US Ambassador Daniel Shapiro for a stern talk. Back with his cabinet, he had told his colleagues in the ministry that the resolution was “reckless and destructive”.

Hence his current ingenuous attitude fails to find takers.

There is, however, some dissent which seems justified. Netanyahu’s attorney general has said that the bill was unconstitutional and that he would not defend it in the Supreme Court. He has a point. He would probably be the one defending it if the case goes to the International Criminal Court at The Hague, Netherlands. That court has already been apprised of a lot of pertinent details and is said to be examining the settlements issue.

The reactions

The Palestinian reaction was as expected. Nabil Abu Rdeneh, a spokesman for Palestinian President Mahmoud Abbas, has said: “This is an escalation that would only lead to more instability and chaos. It is unacceptable. It is denounced and the international community should act immediately.”

The US State Department too has reacted cautiously. It has reportedly said: “The Trump administration will withhold comment on the legislation until the relevant court ruling.”

The move has not received support from the global Jewish advocacy group AJC. Its CEO David Harris has been quoted as saying: “Israel’s High Court can and should reverse this misguided legislation.” 

International legal position

The Fourth Geneva Convention of 1949 prohibits countries from moving population into territories occupied in a war. That, incidentally, was also the year that the state of Israel came into existence.

The trouble has been with Israeli stubbornness and, of course, with massive US support. Israel says this decision of 1949 does not apply to territory occupied during the Six-Day War of 1967. Proving this argument to be specious, the UN Security Council, its General Assembly, the International Committee of the Red Cross, the International Court of Justice and the High Contracting Parties to the Convention have all said that the Fourth Geneva Convention does apply.

Technically that left Israel with the fig leaf of the US support.

Many UN resolutions have clearly said that these settlements, East Jerusalem and the Golan Heights occupations are illegal. The last UN Security Council decision wasn’t the first. Similar rulings had been passed in 1979 and 1980, too.

Israel has deliberately kept its position vis-a-vis the law somewhat vague and has failed to justify its stand about pushing its population into territory that the international community believes is Palestinian.

There has also been talk to equate this issue with the China-Tibet issue, but that has not gained as much traction as this. This is probably because of India’s somewhat weak position vis-a-vis the matter. It is the strength of conviction that keeps the Palestine issue hot around the world. The legal battles, that should ensue and then get lost in the mist, would still be pertinent in the social contexts of these nations.[/vc_column_text][/vc_column][/vc_row]

Latest world news

Trump says Iran getting more serious in talks, no decision yet on major strikes

Donald Trump says Iran is becoming more serious in negotiations with the US but insists no decision has been taken on launching major military strikes against Tehran.

Published

on

Donald Trump

US President Donald Trump has said he has not yet decided whether to authorise major military strikes against Iran, stating that Tehran has become “more serious” in its negotiations with Washington even as tensions between the two countries remain high.

Speaking to reporters in the Oval Office on Friday, Trump said discussions with Iran were continuing and suggested diplomatic efforts were showing signs of progress.

“We’re talking to them right now. I think they’re getting more and more serious as the days go by,” Trump said, adding that no final decision had been taken on launching military action.

Trump says diplomacy remains an option

Trump said the United States remained prepared for military action if required but indicated that ongoing talks could still lead to an agreement.

“We’re locked and loaded and ready to go. But we’re talking to them, so I think while we’re talking, we’ll see what comes of it. I believe they’re very serious. They should be,” he said.

The US President also warned that Iran would face a “much higher level” of strikes if negotiations failed, while reiterating that preventing Tehran from developing a nuclear weapon remained his key red line.

The United States has said its military operations are aimed at preventing Iran from closing the strategically important Strait of Hormuz. Iran, meanwhile, has carried out retaliatory strikes on US bases, with four American service members reported killed.

Reports claim Trump discussed large-scale military operation

Trump’s remarks came after media reports suggested he met senior advisers to discuss the possibility of a large-scale military operation against Iran. Another report said he was considering a “massive attack”, although Trump did not confirm those reports during his interaction with journalists.

He also acknowledged that the prolonged conflict, which he had earlier expected to last only a few weeks, was approaching its fifth month and had become a political challenge ahead of the US midterm elections scheduled for November.

Trump issues warning over support for Iran

Trump also addressed reports claiming that Russia and China were providing intelligence or military support to Iran. He said both Chinese President Xi Jinping and Russian President Vladimir Putin had assured him they would not arm Tehran.

“I think they wouldn’t want to have me disappointed,” Trump said.

In a separate post on his Truth Social platform, Trump warned Moscow and Beijing against supplying weapons to Iran, saying such a move would not be in their interests.

He further stated that Xi had assured him during their meeting in Beijing in May that China would not provide weapons to Iran, while Putin had conveyed a similar position despite the ongoing war in Ukraine.

Continue Reading

India News

For second time, US strikes ship with Indian crew near Strait of Hormuz

Published

on

By

Strait of Hormuz

The United States Central Command (CENTCOM) has said that an oil tanker carrying Indian crew was drifting with its engine switched off near the Strait of Hormuz before it was struck by US forces.

A CENTCOM spokesperson said the vessel had stopped due to engine failure and was drifting after its crew repeatedly sought additional time to carry out repairs. US officials said the tanker was struck only after it failed to comply with directives issued by US forces enforcing a blockade on vessels allegedly transporting Iranian oil. The military said the strike was aimed at disabling the ship by targeting its engine room rather than sinking it.

The incident involved a tanker carrying Indian seafarers near the Gulf of Oman, close to the Strait of Hormuz, one of the world’s busiest maritime trade routes. The strike triggered a fire onboard, prompting rescue efforts by Omani authorities and maritime agencies. Indian authorities closely monitored the situation and coordinated with local officials regarding the welfare of the crew members.

The incident has drawn concern in India, with the government emphasising the safety of Indian nationals working aboard commercial vessels in the conflict-hit region. The Ministry of External Affairs has remained in touch with the authorities concerned as tensions between the United States and Iran continue to pose risks to international shipping.

In June, three Indian sailors were killed in a US strike on another oil tanker. The Strait of Hormuz handles a significant share of the word’s oil trade, and the latest incident has renewed concerns over the security of merchant vessels operating in the region. Maritime experts have warned that escalating hostilities could further disrupt commercial shipping and endanger civilian crews navigating one of the world’s most strategically important waterways.

Continue Reading

Latest world news

Trump announces phased tariff of up to 200% on generic drug imports, India may face impact

US President Donald Trump has announced a phased tariff plan on imported generic medicines, raising duties to 200% after three years, a move that could affect India’s pharmaceutical exports.

Published

on

Donald Trump

The United States has announced a phased tariff plan for imported generic medicines that could have implications for pharmaceutical exporters, including India. US President Donald Trump said the policy is intended to encourage companies to shift generic drug manufacturing to the United States by imposing steep tariffs after a two-year transition period.

The announcement is particularly important for India, one of the world’s largest suppliers of affordable generic medicines and a major exporter to the US market.

Trump outlines phased tariff plan

In a post on his Truth Social platform, President Trump said the new policy will take effect from August 1, 2026. Under the plan, imported generic medicines will continue to attract zero tariffs for the first two years.

Beginning in the third year, the tariff will increase to 100%, before rising further to 200% thereafter.

Trump said the measure is designed to encourage pharmaceutical companies to establish manufacturing facilities in the United States instead of relying on imports.

He added that companies choosing not to invest in US-based production during the transition period would face the higher tariff rates. According to Trump, the existing policy governing patented, branded and innovative medicines will remain unchanged.

Why India could be affected

India is widely regarded as the “pharmacy of the world” because of its large-scale production and export of generic medicines.

Indian generic drugs account for nearly 40% of the US generic medicine market by volume. According to a Global Trade Research Initiative (GTRI) report, India exported pharmaceutical products worth USD 9.7 billion to the United States during the 2024-25 financial year, representing around 38% of the country’s total pharmaceutical exports of USD 25.8 billion.

However, the immediate impact of the newly announced tariff policy on Indian pharmaceutical companies remains uncertain.

Existing trade agreement and industry concerns

India and the United States struck a trade pact in February that states India would receive negotiated outcomes regarding generic pharmaceuticals and pharmaceutical ingredients.

Despite that provision, previous tariff threats by Trump had already raised concerns within the pharmaceutical industry over the future of affordable medicine exports from India.

Indian pharmaceutical companies supply a wide range of generic medicines used to treat conditions including hypertension, diabetes, depression, cancer, infectious diseases and mental health disorders.

According to a Financial Post report cited in the source material, around 65% of birth control pill prescriptions in the United States during 2024 were manufactured by two India-based companies — Glenmark Pharmaceuticals Ltd. and Lupin Ltd.

Continue Reading

Trending

© Copyright 2022 APNLIVE.com